SCHEMBL6653549

SCHEMBL6653549

CC(C)=CCCC(C)=CCOc1ccc(F)cc1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.54
PTGES O14684 6/20 0.51
ALOX15 P16050 6/20 0.47
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
NDUFS8 O00217 1/20 0.46
COXFA4 O00483 1/20 0.46
NDUFAB1 O14561 1/20 0.46
NDUFA1 O15239 1/20 0.46
NDUFS4 O43181 1/20 0.46
NDUFB5 O43674 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6653539 1.00 MTNR1A (0.54) MTNR1APTGESALOX15HDAC3HDAC4
SCHEMBL6651695 0.86 ALOX15 (0.55) MTNR1APTGESALOX15HDAC3HDAC4
SCHEMBL6651692 0.86 ALOX15 (0.55) MTNR1APTGESALOX15HDAC3HDAC4
SCHEMBL31438947 0.85 ICMT (0.56) MTNR1APTGESALOX15TRPV1
SCHEMBL7033631 0.85 ICMT (0.56) MTNR1APTGESALOX15TRPV1
SCHEMBL6652681 0.85 ICMT (0.56) MTNR1APTGESALOX15TRPV1
SCHEMBL31438944 0.85 ICMT (0.56) MTNR1APTGESALOX15TRPV1
SCHEMBL6653805 0.85 ICMT (0.56) MTNR1APTGESALOX15TRPV1
SCHEMBL6650885 0.84 MTNR1A (0.58) MTNR1APTGESALOX15HDAC3HDAC4
SCHEMBL6650890 0.84 MTNR1A (0.58) MTNR1APTGESALOX15HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0875501-B1 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug SHISEIDO CO LTD (JP) 2004-06-16 EP disclosed
EP-0802196-B1 Alkylenediamine derivatives as drugs for the treatment of ulcers and the inhibition of Helicobacter pylori SHISEIDO CO LTD (JP) 2001-08-29 EP disclosed
US-6043243-A Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug SHISEIDO CO., LTD. (JP) 2000-03-28 US disclosed
US-6001880-A DISUBSTITUTED N-(2-DIALKYLAMINOETHYL)BENZAMIDE DERIVATIVES OF GIVEN FORMULA; ANTIBACTERIAL ACTIVITY AGAINST HELICOBACTER PYROLI, ADMINISTERING FOR THE PREVENTION OR CURE OF PEPTIC ULCERS SHISEIDO CO., LTD. (JP) 1999-12-14 US disclosed
US-5925667-A INHIBITS GROWTH OF HELICOBACTER PYLORI SHISEIDO CO., LTD. (JP) 1999-07-20 US disclosed
EP-0875501-A2 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug SHISEIDO COMPANY LIMITED (JP) 1998-11-04 EP disclosed
EP-0869118-A1 Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug SHISEIDO COMPANY LIMITED (JP) 1998-10-07 EP disclosed
US-5814634-A PEPTIC ULCERS, GASTRIC ULCERS SHISEIDO CO. LTD. (JP) 1998-09-29 US disclosed
EP-0802196-A1 Alkylenediamine derivative, antiulcer drug, and antibacterial drug SHISEIDO COMPANY LIMITED (JP) 1997-10-22 EP disclosed